tiprankstipranks
Trending News
More News >
LakeShore Biopharma (LSBCF)
OTHER OTC:LSBCF
US Market

LakeShore Biopharma (LSBCF) Ratios

Compare
92 Followers

LakeShore Biopharma Ratios

LSBCF's free cash flow for Q3 2024 was ¥0.79. For the 2024 fiscal year, LSBCF's free cash flow was decreased by ¥ and operating cash flow was ¥-0.48. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Jun 23Mar 22
Liquidity Ratios
Current Ratio
1.02 1.13 1.57 5.36K
Quick Ratio
0.75 0.87 1.29 4.19K
Cash Ratio
0.03 0.31 0.56 1.90K
Solvency Ratio
-0.07 -0.42 -0.11 -10.10
Operating Cash Flow Ratio
-0.15 -0.37 -0.28 -4.30
Short-Term Operating Cash Flow Coverage
-0.31 -0.93 -0.94 >-0.01
Net Current Asset Value
¥ ―¥ -25.69M¥ -24.65M¥ 44.68M¥ 744.41M
Leverage Ratios
Debt-to-Assets Ratio
0.30 0.28 0.29 1.89
Debt-to-Equity Ratio
0.83 0.73 0.68 0.57
Debt-to-Capital Ratio
0.45 0.42 0.41 0.36
Long-Term Debt-to-Capital Ratio
0.04 0.14 0.29 0.27
Financial Leverage Ratio
2.74 2.59 2.36 0.30
Debt Service Coverage Ratio
-0.12 -0.96 -0.35 -0.63
Interest Coverage Ratio
-5.48 -10.05 -4.52 -43.78
Debt to Market Cap
0.22 0.07 0.06 0.02
Interest Debt Per Share
4.02 4.38 6.84 12.99
Net Debt to EBITDA
-7.96 -0.48 -1.67 -1.63
Profitability Margins
Gross Profit Margin
82.47%79.48%77.68%75.85%
EBIT Margin
-13.85%-71.65%-16.51%-19.55%
EBITDA Margin
-7.89%-64.29%-11.18%-13.36%
Operating Profit Margin
-14.03%-77.75%-20.28%-23.65%
Pretax Profit Margin
-16.41%-79.38%-41.09%-46.07%
Net Profit Margin
-16.26%-75.59%-21.17%-47.06%
Continuous Operations Profit Margin
-16.26%-75.59%-41.25%-47.06%
Net Income Per EBT
99.06%95.23%51.53%102.13%
EBT Per EBIT
116.96%102.10%202.56%194.80%
Return on Assets (ROA)
-7.31%-28.65%-8.46%-117.72%
Return on Equity (ROE)
-20.01%-74.07%-19.97%-35.26%
Return on Capital Employed (ROCE)
-15.89%-62.72%-13.14%-59.22%
Return on Invested Capital (ROIC)
-9.15%-41.04%-11.07%-11.01%
Return on Tangible Assets
-7.72%-30.06%-8.86%-196.70%
Earnings Yield
-5.26%-7.73%-1.71%-1.30%
Efficiency Ratios
Receivables Turnover
1.23 1.29 1.47 1.63
Payables Turnover
2.17 1.74 1.91 3.94
Inventory Turnover
0.47 0.58 0.83 0.73
Fixed Asset Turnover
1.48 1.19 1.18 0.89
Asset Turnover
0.45 0.38 0.40 2.50
Working Capital Turnover Ratio
10.39 2.40 1.20 0.87
Cash Conversion Cycle
900.81 703.42 498.44 631.70
Days of Sales Outstanding
297.83 282.72 248.68 223.92
Days of Inventory Outstanding
770.80 630.90 441.21 500.37
Days of Payables Outstanding
167.82 210.20 191.45 92.59
Operating Cycle
1.07K 913.62 689.89 724.29
Cash Flow Ratios
Operating Cash Flow Per Share
-1.13 -2.76 -2.36 -0.02
Free Cash Flow Per Share
-1.30 -3.17 -3.09 -10.15
CapEx Per Share
0.17 0.41 0.74 10.13
Free Cash Flow to Operating Cash Flow
1.15 1.15 1.31 488.48
Dividend Paid and CapEx Coverage Ratio
-6.77 -6.67 -3.20 >-0.01
Capital Expenditure Coverage Ratio
-6.77 -6.67 -3.20 >-0.01
Operating Cash Flow Coverage Ratio
-0.29 -0.70 -0.37 >-0.01
Operating Cash Flow to Sales Ratio
-0.20 -0.51 -0.27 >-0.01
Free Cash Flow Yield
-7.30%-6.06%-2.82%-1.65%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-19.01 -12.93 -58.47 -76.76
Price-to-Sales (P/S) Ratio
3.09 9.77 12.38 36.12
Price-to-Book (P/B) Ratio
3.80 9.58 11.68 27.06
Price-to-Free Cash Flow (P/FCF) Ratio
-13.69 -16.51 -35.52 -60.65
Price-to-Operating Cash Flow Ratio
-15.71 -18.98 -46.62 -29.62K
Price-to-Earnings Growth (PEG) Ratio
0.25 -0.11 >-0.01 0.77
Price-to-Fair Value
3.80 9.58 11.68 27.06
Enterprise Value Multiple
-47.12 -15.69 -112.44 -271.98
Enterprise Value
2.29B 5.78B 8.64B 18.28B
EV to EBITDA
-47.12 -15.69 -112.44 -271.98
EV to Sales
3.72 10.08 12.57 36.34
EV to Free Cash Flow
-16.47 -17.03 -36.05 -61.01
EV to Operating Cash Flow
-18.91 -19.59 -47.32 -29.80K
Tangible Book Value Per Share
3.99 4.81 8.40 3.39
Shareholders’ Equity Per Share
4.67 5.47 9.41 22.75
Tax and Other Ratios
Effective Tax Rate
<0.01 0.05 >-0.01 -0.02
Revenue Per Share
5.75 5.36 8.88 17.05
Net Income Per Share
-0.94 -4.05 -1.88 -8.02
Tax Burden
0.99 0.95 0.52 1.02
Interest Burden
1.18 1.11 2.49 2.36
Research & Development to Revenue
0.24 0.53 0.46 0.42
SG&A to Revenue
0.22 0.26 0.12 0.21
Stock-Based Compensation to Revenue
0.02 0.02 <0.01 0.02
Income Quality
1.21 0.68 1.25 <0.01
Currency in CNY